Antimicrobial central venous catheters do not reduce infections in pre-term babies

Area of Science:

• Neonatal Medicine
• Infectious Disease Prevention
• Medical Devices

Background:

• Neonatal bloodstream infections (BSI) are a significant cause of morbidity and mortality in preterm infants.
• Central venous catheters (CVCs) are essential for neonatal care but increase the risk of BSI.
• Preventing CVC-related infections in this population remains a critical clinical challenge.

Purpose of the Study:

• To evaluate the effectiveness of antimicrobial-impregnated central venous catheters (AI-CVCs) in preventing BSI in preterm infants.
• To compare the incidence of BSI in neonates receiving AI-CVCs versus standard CVCs.
• To inform clinical practice guidelines for infection control in neonatal intensive care units.

Main Methods:

• An open-label, parallel-group, pragmatic, randomised controlled trial (PREVAIL study) was conducted.
• Preterm infants requiring CVC insertion were randomly assigned to receive either AI-CVCs or standard CVCs.
• The primary outcome was the incidence of laboratory-confirmed bloodstream infection.

Main Results:

• There was no statistically significant difference in the incidence of BSI between the AI-CVC group and the standard CVC group.
• The study did not demonstrate a reduction in neonatal bloodstream infections with the use of antimicrobial-impregnated catheters.
• No significant difference in other catheter-related complications was observed between the groups.

Conclusions:

• Antimicrobial-impregnated central venous catheters are not effective in reducing the incidence of bloodstream infections in preterm infants.
• Current infection prevention strategies for neonatal CVCs may need re-evaluation.
• Further research into alternative methods for preventing BSI in vulnerable preterm neonates is warranted.